StrandSmartTM is a California based new-age diagnostics company with a data-driven approach to stage-shifting cancer.

Our team is developing a blood testing platform engineered to bridge the gap from early detection to personalised cancer treatment selection.

Most cancers are detected at later stages, when survival rates are lower and treatments are more costly and potentially harmful.

We accompany screening modalities to make sure patients who need an immediate biopsy get one.

We envision a world where cancers are caught early enough to be curable or better managed.


Cancer is a data problem, and the solution is data driven

If you have inquiries related to clinical trials, employment opportunities, investment opportunities, or other inquiries:

Click here

OUR FOUNDING TEAM

Adrianna Davies
Chief Executive Officer

Mark D. Myslinski
Chief Product Officer

Wesley D. Blakeslee
General Counsel

Diana Maichin
Chief Operating Officer

If you have inquiries related to clinical trials, employment opportunities, investment opportunities, or other inquiries:

Click here

Copyright © 2021 StrandSmartTM, Inc. All Rights Reserved.

Data driven

New-age diagnostics

Stage-shifting cancer

Dr. John Park, MD
Chief Scientific Officer

TM

Mark Connelly, PhD
VP of R &D

Rex Yung, MD
Chief Medical Adviser

Backed by: